Rewind Therapeutics
Latest round
- Series A
Last raised
- Dec 2017
Total raised
- $18M
Investors
- 4
About Rewind Therapeutics
Rewind Therapeutics is engaged in the development of advanced biotherapeutics targeting specific disease mechanisms. Founded in Leuven, Belgium, the company has evolved strategically without major pivots.U. Leuven Research & Development, and others. The company's founder has a history of involvement in biotechnology ventures but specific details on previous companies are not disclosed.Rewind Therapeutics specializes in the development of innovative therapeutic solutions aimed at addressing unmet medical needs within the healthcare landscape. The company's core product offerings focus on advanced biotherapeutics designed to target specific disease mechanisms, thereby improving patient outcomes. Their flagship products are formulated to enhance treatment efficacy for conditions where traditional therapies have proven inadequate. Aimed at healthcare providers and institutions, these products cater to both acute and chronic conditions, with particular emphasis on applications in oncology and neurodegenerative diseases.The revenue model of Rewind Therapeutics is structured around both direct-to-consumer and business-to-business transactions, reflecting a diverse client base that includes healthcare providers, hospitals, and research institutions. The company engages in partnerships with healthcare systems and pharmaceutical distributors to facilitate the delivery of its products, establishing a robust channel for revenue generation. Transactions typically involve bulk purchasing agreements for their therapeutic products, which may include subscription-based services for ongoing support and education on product usage. Pricing structures are aligned with industry standards, focusing on value-driven solutions that meet the needs of their clients while ensuring accessibility for end-users. The company is focused on launching new therapeutic products in the coming years, targeting the oncology and neurodegenerative treatment markets. Expansion efforts include increasing market presence in North America and Europe, with specific initiatives aimed for 2024.
Who invested in Rewind Therapeutics
4 investors across 1 round
See all investors in Rewind Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 22, 2017
Amount
$18M
Investors
Questions about Rewind Therapeutics
Who invested in Rewind Therapeutics?
Rewind Therapeutics has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Rewind Therapeutics raised?
Rewind Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Rewind Therapeutics last raise money?
Rewind Therapeutics's most recent round on record is a Series A, in Dec 2017.
What does Rewind Therapeutics do?
Rewind Therapeutics is engaged in the development of advanced biotherapeutics targeting specific disease mechanisms.
Where is Rewind Therapeutics headquartered?
Rewind Therapeutics is headquartered in Leuven, Belgium.
Which VCs invest in companies like Rewind Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back pharmaceuticals companies at Rewind Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Rewind Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.